This inventor holds 1 USPTO granted patent. Top assignee: Morishita Jintan Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kazuma Takahashi: Innovator in Delayed Disintegration-Type Capsules
Introduction
Kazuma Takahashi is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the design of capsules that enhance the delivery of active substances.
Latest Patents
Takahashi holds a patent for a "Delayed disintegration-type capsule and method for producing same." The objective of this invention is to provide a technique for delaying the disintegration of a capsule by blending specific components in the core. This innovation increases the degree of freedom in capsule design. The patent describes a seamless capsule that includes a core containing an active substance, an amphoteric surfactant, and a fat with a melting point of 40° C. or more. Additionally, at least one intermediate layer contains a fat with a melting point of 45° C. or more, while the outermost layer consists of a water-soluble natural polymer. The invention also outlines a method for producing these capsules.
Career Highlights
Kazuma Takahashi is currently associated with Morishita Jintan Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing capsule technology, which is crucial for effective drug delivery.
Collaborations
Takahashi has collaborated with notable colleagues, including Takehiro Nishikawa and Katsutoshi Ishii. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kazuma Takahashi's contributions to the field of delayed disintegration-type capsules exemplify his commitment to innovation in pharmaceutical technology. His work not only enhances capsule design but also improves the efficacy of drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile